Status:
TERMINATED
Immune Reconstitution in naïve HIV Patients With CD4 <100 Cells/mL When Treated With Lopinavir or Efavirenz.
Lead Sponsor:
Hospital Clinic of Barcelona
Conditions:
HIV Infection
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Pilot, randomized, parallel, open-label, controlled, clinical study evaluating virological response in plasma and extra-plasmatic compartments, together with the degree and kinetics of immune reconsti...
Eligibility Criteria
Inclusion
- HIV-infection
- Antiretroviral-naive
- CD4 cell count below 100 cells/mm3
Exclusion
- Pregnancy
- Current opportunistic infection requiring parenteral therapy
- Current malignancies requiring parenteral chemotherapy
- Any contraindication to the study drugs
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00386659
Last Update
October 11 2006
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital de Sant Pau
Barcelona, Barcelona, Spain, 08025
2
Hospital Vall d'Hebron
Barcelona, Barcelona, Spain, 08035
3
Hospital Clinic
Barcelona, Barcelona, Spain, 08036
4
CSU Bellvitge
L'Hospitalet de Llobregat, Barcelona, Spain, 08907